Mimedx Group Inc (MDXG-Q) Stock Price and News

MiMedx is an integrated developer, processor and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. `Innovations in Regenerative Biomaterials` is the framework behind their mission to give physicians products and tissues to help the body heal itself. Their biomaterial platform technologies include AmnioFix and EpiFix, their tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through their donor program, a mother delivering via full-term Caesarean section birth can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. They process the human amniotic membrane utilizing their proprietary PURION Process, to produce a safe and effective implant.

Markets News

Before the Bell: What every Canadian investor needs to know today

Small caps to watch: NFI Group, Algoma, Aecon, Bird, North American construction, and more

${"Id":780514,"Name":"Don't expect big lift in stocks due to 'January Effect': Stephenson","Desc":"John Stephenson, President and CEO, Stephenson & Company discusses the so-called \"January effect\" and whether he thinks it will make a difference for markets in 2016.","ShortDesc":"John Stephenson, President and CEO, Stephenson & Company discusses the so-called \"January effect\" and whether he thinks it will make a...","Type":"segment","Episode":null,"AgvotCode":"E","AgvotDisclaimer":null,"QfrCode":"G","AiringOrder":null,"BroadcastDate":"2016-01-04","BroadcastTime":"08:10:15","BroadcastDateTime":"2016-01-04T08:10:15-05:00","LastModifiedDateTime":"2016-01-04T14:23:28Z","GameId":null,"Album":null,"Genres":[{"Id":154,"Name":"Commentary"},{"Id":40,"Name":"Investing"}],"Keywords":[{"Id":66203,"Name":"john stephenson","Count":139},{"Id":64202,"Name":"President","Count":273},{"Id":61326,"Name":"CEO","Count":342},{"Id":78657,"Name":"Stephenson & Company","Count":61},{"Id":70011,"Name":"january effect","Count":1},{"Id":61275,"Name":"markets","Count":1303},{"Id":61269,"Name":"stocks","Count":553},{"Id":75870,"Name":"tax-loss selling","Count":5},{"Id":63123,"Name":"small caps","Count":54},{"Id":63054,"Name":"prices","Count":20},{"Id":69699,"Name":"december","Count":2},{"Id":64558,"Name":"january","Count":0}],"Tags":[],"Images":[{"Type":"thumbnail","Url":"http://images.9c9media.com/image_asset/2016_1_4_a0629a30-951c-0133-524d-34b52f6f1279_jpg_940x529.jpg","Width":940,"Height":529}],"Authentication":{"Required":false,"Resources":null},"RatingWarnings":[],"People":[],"Funding":null,"MusicLabels":[],"BroadcastNetworks":[]}$

opinion

The U.S. dollar’s quiet decline: What investors should do now

Sam Sivarajan

MDXG-Q: STOCK REPORT

Value Target Price

SIMILAR TO MDXG-Q

ETFS WITH MDXG-Q

Symbol	Name

Latest in

More

Instrument NameMimedx Group IncInstrument Symbol(MDXG-Q)Instrument ExchangeNASDAQ

TOP STORIES: Mimedx Group Inc

Profile

Instrument NameMimedx Group IncInstrument Symbol(MDXG-Q)
Instrument ExchangeNASDAQ